-+ 0.00%
-+ 0.00%
-+ 0.00%

Dexcom Presents New G7 Registry Data Showing A1C And Weight Management Improvements In Non-Insulin Type 2 Diabetes Patients At ATTD 2026

Benzinga·03/11/2026 06:28:14
Listen to the news
  • New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren't on insulin therapy1, reinforcing the need to broaden CGM access beyond insulin-treated populations.
  • During its symposium on Thursday, March 12, Dexcom will share upcoming product features across its global portfolio.
  • Two in-booth, expert-led presentations on Thursday, March 12, and Friday, March 13 will showcase the first consensus‑based CGM competency framework to give healthcare professionals a clear, role‑aligned structure for delivering confident, consistent CGM support.2